Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Aneurysm & intracranial embolization · New York | Aneurysm & intracranial embolization · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 25 | 29 |
| Medicare fee-for-service cases | 1,148 | 803 |
| Growth since 2019 (Medicare FFS) | +12%/yr | +20%/yr |
| Forecast cases (Medicare FFS) | 1,980 in 2030 | 1,470 in 2030 |
| Forecast growth | +9.5%/yr to 2030 | +11%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.6 | 0.6 |
| Medicare Advantage share | 57% | 58% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 46 | 28 |
| Top 10 surgeons' share | 61% | 47% |
| Surgeons growing | 5 | 1 |
| New since the base year | 7 | 8 |
| Likely to stop billing it | 4 by 2026 | 8 by 2026 |
| Forecast miss, 1 year (procedure) | 13% | 13% |
| Company payments per surgeon | $41K | $20K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.